Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wounds, Nonpenetrating | 3 | 2016 | 108 | 1.280 |
Why?
|
| Laparoscopy | 9 | 2025 | 472 | 0.910 |
Why?
|
| Pancreas | 2 | 2016 | 150 | 0.590 |
Why?
|
| Abdominal Injuries | 1 | 2016 | 30 | 0.500 |
Why?
|
| Fundoplication | 2 | 2025 | 25 | 0.430 |
Why?
|
| Infant | 12 | 2025 | 1648 | 0.420 |
Why?
|
| Internship and Residency | 4 | 2025 | 800 | 0.400 |
Why?
|
| Wounds, Penetrating | 1 | 2012 | 26 | 0.380 |
Why?
|
| General Surgery | 2 | 2025 | 210 | 0.380 |
Why?
|
| Child | 16 | 2025 | 4520 | 0.370 |
Why?
|
| Child, Preschool | 11 | 2025 | 1988 | 0.350 |
Why?
|
| Spleen | 1 | 2012 | 483 | 0.350 |
Why?
|
| Retrospective Studies | 17 | 2025 | 6596 | 0.330 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2009 | 14 | 0.320 |
Why?
|
| Dextrans | 1 | 2009 | 46 | 0.320 |
Why?
|
| Hernia, Inguinal | 2 | 2022 | 41 | 0.310 |
Why?
|
| Prostheses and Implants | 1 | 2009 | 71 | 0.310 |
Why?
|
| Hyaluronic Acid | 1 | 2009 | 67 | 0.300 |
Why?
|
| Herniorrhaphy | 3 | 2025 | 70 | 0.300 |
Why?
|
| Infant, Newborn | 7 | 2025 | 1355 | 0.300 |
Why?
|
| Intestinal Obstruction | 2 | 2012 | 53 | 0.290 |
Why?
|
| Appendicitis | 3 | 2018 | 81 | 0.280 |
Why?
|
| Treatment Outcome | 14 | 2025 | 5625 | 0.270 |
Why?
|
| Gastroesophageal Reflux | 2 | 2025 | 92 | 0.270 |
Why?
|
| Digestive System Abnormalities | 1 | 2007 | 3 | 0.270 |
Why?
|
| Adolescent | 11 | 2025 | 6229 | 0.260 |
Why?
|
| Postoperative Complications | 6 | 2025 | 1293 | 0.260 |
Why?
|
| Intestinal Diseases | 1 | 2007 | 36 | 0.260 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2007 | 91 | 0.250 |
Why?
|
| Injury Severity Score | 2 | 2016 | 108 | 0.240 |
Why?
|
| Histamine H2 Antagonists | 1 | 2025 | 15 | 0.240 |
Why?
|
| Hernia, Umbilical | 1 | 2025 | 7 | 0.240 |
Why?
|
| Proton Pump Inhibitors | 1 | 2025 | 42 | 0.230 |
Why?
|
| Narration | 1 | 2025 | 47 | 0.230 |
Why?
|
| Gift Giving | 1 | 2024 | 8 | 0.230 |
Why?
|
| Female | 22 | 2025 | 32707 | 0.230 |
Why?
|
| Male | 20 | 2025 | 29717 | 0.220 |
Why?
|
| Humans | 31 | 2025 | 63146 | 0.220 |
Why?
|
| Education, Medical, Graduate | 3 | 2025 | 350 | 0.220 |
Why?
|
| Appendix | 2 | 2018 | 17 | 0.210 |
Why?
|
| Meckel Diverticulum | 1 | 2003 | 3 | 0.210 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2018 | 1606 | 0.200 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 171 | 0.200 |
Why?
|
| Pyloric Stenosis | 1 | 2002 | 4 | 0.200 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2002 | 25 | 0.190 |
Why?
|
| Fetal Diseases | 1 | 2002 | 21 | 0.190 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2002 | 11 | 0.190 |
Why?
|
| Interviews as Topic | 1 | 2024 | 509 | 0.190 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2002 | 43 | 0.190 |
Why?
|
| Anesthesia, Spinal | 1 | 2022 | 30 | 0.190 |
Why?
|
| Hepatoblastoma | 1 | 2002 | 9 | 0.190 |
Why?
|
| Musa | 1 | 2021 | 7 | 0.190 |
Why?
|
| Pyloric Stenosis, Hypertrophic | 1 | 2021 | 8 | 0.190 |
Why?
|
| Pyloromyotomy | 1 | 2021 | 8 | 0.190 |
Why?
|
| Doxorubicin | 1 | 2002 | 99 | 0.180 |
Why?
|
| Cisplatin | 1 | 2002 | 139 | 0.180 |
Why?
|
| Femoral Artery | 1 | 2002 | 110 | 0.180 |
Why?
|
| Suture Techniques | 2 | 2019 | 99 | 0.170 |
Why?
|
| Renal Dialysis | 1 | 2002 | 198 | 0.170 |
Why?
|
| Length of Stay | 4 | 2015 | 808 | 0.170 |
Why?
|
| Liver Neoplasms | 1 | 2002 | 297 | 0.150 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2002 | 310 | 0.150 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2002 | 447 | 0.140 |
Why?
|
| Educational Measurement | 1 | 2019 | 217 | 0.140 |
Why?
|
| Ultrasonography | 1 | 2018 | 481 | 0.130 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 935 | 0.130 |
Why?
|
| Thoracic Injuries | 1 | 2016 | 43 | 0.120 |
Why?
|
| Follow-Up Studies | 4 | 2025 | 2452 | 0.120 |
Why?
|
| Databases, Factual | 2 | 2015 | 862 | 0.120 |
Why?
|
| Logistic Models | 2 | 2015 | 1274 | 0.120 |
Why?
|
| Clinical Competence | 1 | 2019 | 725 | 0.110 |
Why?
|
| Pectus Carinatum | 1 | 2014 | 4 | 0.110 |
Why?
|
| Braces | 1 | 2014 | 10 | 0.110 |
Why?
|
| Child Advocacy | 1 | 2013 | 7 | 0.100 |
Why?
|
| Wounds, Gunshot | 1 | 2013 | 56 | 0.100 |
Why?
|
| Tissue Adhesions | 1 | 2012 | 20 | 0.100 |
Why?
|
| Splenectomy | 1 | 2012 | 42 | 0.100 |
Why?
|
| Firearms | 1 | 2013 | 69 | 0.090 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2012 | 34 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 288 | 0.090 |
Why?
|
| Bites and Stings | 1 | 2011 | 11 | 0.090 |
Why?
|
| Hospital Mortality | 2 | 2013 | 874 | 0.090 |
Why?
|
| Facial Injuries | 1 | 2011 | 14 | 0.090 |
Why?
|
| Appendectomy | 2 | 2018 | 54 | 0.090 |
Why?
|
| Wound Infection | 1 | 2011 | 28 | 0.090 |
Why?
|
| Colectomy | 1 | 2012 | 108 | 0.090 |
Why?
|
| Cicatrix | 1 | 2011 | 61 | 0.090 |
Why?
|
| Sutures | 2 | 2016 | 41 | 0.090 |
Why?
|
| Soft Tissue Infections | 1 | 2011 | 49 | 0.090 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2011 | 65 | 0.080 |
Why?
|
| Community-Acquired Infections | 1 | 2011 | 94 | 0.080 |
Why?
|
| Dogs | 1 | 2011 | 325 | 0.080 |
Why?
|
| Staphylococcal Infections | 1 | 2011 | 129 | 0.080 |
Why?
|
| Retreatment | 1 | 2009 | 47 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2012 | 2560 | 0.080 |
Why?
|
| Laparoscopes | 1 | 2007 | 25 | 0.070 |
Why?
|
| Touch | 1 | 2007 | 27 | 0.070 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2007 | 33 | 0.070 |
Why?
|
| Task Performance and Analysis | 1 | 2007 | 126 | 0.070 |
Why?
|
| Massachusetts | 2 | 2025 | 2074 | 0.060 |
Why?
|
| Intussusception | 1 | 2006 | 14 | 0.060 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 2671 | 0.060 |
Why?
|
| Cellulose, Oxidized | 1 | 2005 | 2 | 0.060 |
Why?
|
| Paraplegia | 1 | 2005 | 7 | 0.060 |
Why?
|
| Umbilicus | 1 | 2025 | 16 | 0.060 |
Why?
|
| Spinal Cord Compression | 1 | 2005 | 29 | 0.060 |
Why?
|
| Operative Time | 1 | 2025 | 91 | 0.060 |
Why?
|
| Thoracoscopy | 1 | 2004 | 25 | 0.050 |
Why?
|
| Reoperation | 1 | 2025 | 290 | 0.050 |
Why?
|
| Personnel Selection | 1 | 2024 | 55 | 0.050 |
Why?
|
| Career Choice | 1 | 2025 | 130 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 417 | 0.050 |
Why?
|
| Pain, Postoperative | 1 | 2025 | 162 | 0.050 |
Why?
|
| Comorbidity | 1 | 2007 | 1118 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2003 | 79 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2002 | 30 | 0.050 |
Why?
|
| Life Tables | 1 | 2002 | 23 | 0.050 |
Why?
|
| Ligation | 1 | 2022 | 38 | 0.050 |
Why?
|
| Polytetrafluoroethylene | 1 | 2002 | 18 | 0.050 |
Why?
|
| Pylorus | 1 | 2021 | 10 | 0.050 |
Why?
|
| Prosthesis-Related Infections | 1 | 2002 | 34 | 0.050 |
Why?
|
| Vascular Patency | 1 | 2002 | 139 | 0.050 |
Why?
|
| Educational Status | 1 | 2022 | 275 | 0.050 |
Why?
|
| Preoperative Care | 1 | 2002 | 191 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2013 | 769 | 0.040 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2002 | 224 | 0.040 |
Why?
|
| Formative Feedback | 1 | 2019 | 8 | 0.040 |
Why?
|
| Adult | 3 | 2025 | 16732 | 0.040 |
Why?
|
| Equipment and Supplies | 1 | 2019 | 19 | 0.040 |
Why?
|
| Self-Assessment | 1 | 2019 | 60 | 0.040 |
Why?
|
| Video Recording | 1 | 2019 | 134 | 0.040 |
Why?
|
| Lung | 1 | 2004 | 952 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 2573 | 0.040 |
Why?
|
| Incidence | 2 | 2013 | 1373 | 0.040 |
Why?
|
| Age Factors | 2 | 2013 | 1559 | 0.040 |
Why?
|
| Pandemics | 1 | 2022 | 672 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2016 | 84 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 1543 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 199 | 0.030 |
Why?
|
| Wound Healing | 1 | 2016 | 189 | 0.030 |
Why?
|
| Curriculum | 1 | 2019 | 591 | 0.030 |
Why?
|
| Pregnancy | 1 | 2002 | 2326 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2016 | 1004 | 0.030 |
Why?
|
| Ovarian Cysts | 1 | 2012 | 4 | 0.020 |
Why?
|
| Hospital Charges | 1 | 2012 | 23 | 0.020 |
Why?
|
| Urban Population | 1 | 2013 | 193 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2012 | 49 | 0.020 |
Why?
|
| Young Adult | 2 | 2013 | 4671 | 0.020 |
Why?
|
| Neutropenia | 1 | 2012 | 67 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 579 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2012 | 241 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2014 | 360 | 0.020 |
Why?
|
| Unnecessary Procedures | 1 | 2011 | 44 | 0.020 |
Why?
|
| Soft Tissue Injuries | 1 | 2011 | 21 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2011 | 55 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 498 | 0.020 |
Why?
|
| Operating Rooms | 1 | 2011 | 55 | 0.020 |
Why?
|
| Poverty | 1 | 2013 | 296 | 0.020 |
Why?
|
| Emergencies | 1 | 2011 | 115 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 777 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2011 | 253 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 259 | 0.020 |
Why?
|
| Drainage | 1 | 2011 | 154 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 978 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 671 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2011 | 220 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2012 | 192 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 2179 | 0.020 |
Why?
|
| Animals | 3 | 2016 | 20613 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 969 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 1645 | 0.020 |
Why?
|
| United States | 2 | 2013 | 7822 | 0.020 |
Why?
|
| Enema | 1 | 2006 | 14 | 0.020 |
Why?
|
| Equipment Design | 1 | 2007 | 345 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2013 | 2066 | 0.020 |
Why?
|
| Mediastinal Neoplasms | 1 | 2005 | 20 | 0.010 |
Why?
|
| Foreign-Body Migration | 1 | 2005 | 21 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 784 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 2005 | 52 | 0.010 |
Why?
|
| Iatrogenic Disease | 1 | 2005 | 60 | 0.010 |
Why?
|
| Middle Aged | 1 | 2002 | 17477 | 0.010 |
Why?
|
| Insufflation | 1 | 2004 | 9 | 0.010 |
Why?
|
| Radiography | 1 | 2006 | 540 | 0.010 |
Why?
|
| Pressure | 1 | 2004 | 79 | 0.010 |
Why?
|
| Patient Selection | 1 | 2006 | 486 | 0.010 |
Why?
|
| Models, Animal | 1 | 2004 | 236 | 0.010 |
Why?
|
| Swine | 1 | 2004 | 370 | 0.010 |
Why?
|
| Biopsy | 1 | 2004 | 433 | 0.010 |
Why?
|
| Prognosis | 1 | 2006 | 1741 | 0.010 |
Why?
|
| Biomarkers | 1 | 2006 | 1393 | 0.010 |
Why?
|